Conversely, BRCA2 PV carrier patients have been observed to exhibit a higher incidence of female BC (74% vs. 60%) characterized by earlier age of onset (diagnosis under age 35 years: 26% vs. 11%), bilateral female BC and male BC, compared to BRCA1 PV carrier patients. The gene discussed is BRCA1; the disease is breast cancer.